Axial spondyloarthritis versus axial psoriatic arthritis: Different entities?May 9, 2023Psoriatic ArthritisPsoriasis
COVID-19 and psoriasis: Is there a link?May 4, 2023PsoriasisInfectious DiseasesCOVID-19 UpdatesPsoriatic Arthritis
Meta-analysis examines cancer risk concern for JAK inhibitorsApril 26, 2023Psoriatic ArthritisPediatricsPsoriasis
NPF provides guidance for virtual psoriasis visitsApril 24, 2023PsoriasisMedical DermatologyBusiness of MedicinePsoriatic Arthritis
Biosimilars and patients: Discussions should address safety, cost, and anxiety about changeMarch 30, 2023Business of MedicinePsoriatic ArthritisPediatricsRare DiseasesPsoriasisAutoimmune Diseases
FDA approves new formulation of Hyrimoz adalimumab biosimilarMarch 27, 2023Psoriatic ArthritisPediatricsPsoriasis
New data forecast more oral PDE4 inhibitors for psoriasisMarch 27, 2023PsoriasisAtopic DermatitisPsoriatic Arthritis
Biologics show signs of delaying arthritis in psoriasis patientsMarch 9, 2023Psoriatic ArthritisPsoriasis
Isolated nail psoriasis may bring arthritis into playFebruary 28, 2023PsoriasisPsoriatic ArthritisHair & Nails
Treating nail psoriasis: Intralesional injections and biologicsFebruary 23, 2023PsoriasisHair & NailsPsoriatic Arthritis
What’s holding back physicians from prescribing biosimilars? Four specialties weigh inFebruary 23, 2023Business of MedicinePsoriatic ArthritisPediatricsPsoriasis
New influx of Humira biosimilars may not drive immediate changeFebruary 22, 2023Autoimmune DiseasesPsoriasisPsoriatic ArthritisBusiness of Medicine
